Use of a pulmonary artery catheter (PAC) for hemodynamic monitoring in patients with severe heart failure is controversial, partly because its effect on patients' outcomes is uncertain.
Moreover, the increasing prevalence of vascular heart diseases is expected to propel the growth of the cardiovascular catheter market. Vascular heart diseases are conditions affecting the blood ...